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Abstract
In this study we estimate the subcutaneous tissue counter pressure during drug infusion from a series of injections of insulin
in type 2 diabetic patients using a non-invasive method. We construct a model for the pressure evolution in subcutaneous
tissue based on mass continuity and the flow laws of a porous medium. For equivalent injection forces we measure the
change in the infusion rate between injections in air at atmospheric pressure and in tissue. From a best fit with our model,
we then determine the flow permeability as well as the bulk modulus of the tissue, estimated to be of the order 10211–
10210 m2 and 105 Pa, respectively. The permeability is in good agreement with reported values for adipose porcine tissue.
We suggest our model as a general way to estimate the pressure build-up in tissue during subcutaneous injection.
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Introduction
Diabetics are treated by several daily injections of insulin, most
commonly delivered subcutaneously from where the insulin gets
absorbed by the blood vessels. The injections are typically
performed using an insulin pen or normal syringe. Due to the
high frequency of injections for diabetics, increased patient
convenience is of great importance and devices are therefore
continuously improved to simplify treatment.
The force delivered by injection devices, either injection pumps
or auto-injection devices, must overcome both the resistance in the
injection system and the resistance in the body tissue to make
room for the insulin bolus. The second part we refer to as the
tissue counter pressure. The subcutaneous compartment is
decomposed mainly of two components; adipose tissue and
interstitial tissue. Adipose tissue consists of adipocytes assembled
in lobules separated by a thin layer of connective tissue and nerves
and blood vessels running between the lobules. The interstitial
tissue is placed between the adipocytes and consists mainly of a
fibre framework made of collagen embedded in a mucopolysac-
charide gel [1,2]. Insulin therapy may lead to skin disorders, where
the most common is lipohypertrophy, where extra adipose tissue is
accumulated under the skin. The risk of developing lipohyper-
trophy increases with the time the patients have been treated, the
frequency of changing the needle and injection site [3–6].
Lipoatrophy is a rarer condition, mostly related to impurities in
insulin formulations. In lipoatrophy the size of the adipocytes in
subcutis decreases around the injection site [7–9]. These kind of
skin disorders impair in some cases the insulin absorption
[5,10,11], but as the skin structure is changed it might also
change the tissue counter pressure and affect the way the drug is
delivered by the injection device.
The interstitial fluid pressure in subcutis has been measured by
the wick clamp technique to be of the order 21.3 mbar, when not
subjected to mechanical stress [13,14] and it has been shown that
the tissue counter pressure in subcutis increases with increasing
infusion rate for continuous saline infusion from about 8 mbar to
60 mbar for infusion rates from 0.16 mL/s to 8.3 mL/s [15], in a
study targeting insulin infusion pumps. To our knowledge the
infusion pressure has not been measured for subcutaneous
injections at injection speeds of the order 100 mL/s, which is the
common infusion rate using an insulin pen [16].
In this study we present a non-invasive technique for measuring
the tissue counter pressure during a normal insulin injection. We
use an auto-injection device, where a click signal gives information
on the flow rate. By comparing the infusion rate for subcutaneous
injections and reference injections in air, we calculate the tissue
counter pressure. We propose a model for the pressure evolution
in subcutaneous tissue and from that we estimate the flow
permeability and bulk modulus of the tissue.
Materials and Methods
Ethical approval
The study involving human subjects was conducted in
collaboration with Steno Diabetes Center A/S. While a nurse
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administered insulin to the patient, the audible clicks, emitted from
the injection device, were recorded by microphone. Prior to the
investigation The Committee on Health Research Ethics from the
Capital Region of Denmark reviewed the project. The conclusion
from the committee was that the project could be conducted
without further ethical approval because of its limited intervention.
The participating patients all had type 2 diabetes and received
regular control of their diabetes at Steno Diabetes Center. The
responsible nurse contacted the patients prior to their control visit
and questioned them about participation in the study. The head of
the Clinical Research Department, who was responsible for the
conduct of the study, approved the inclusion of patients without
written informed consent, after acceptance of this procedure by
The Committee on Health Research Ethics from the Capital
Region of Denmark. No institutional review process was necessary
to take this decision. The only restriction to the selection of
subjects was that their insulin dose should be above 18 units to
have a sufficiently long sound file for the subsequent analysis. All
patients that were asked to participate gave their consent.
Experimental design
To measure the pressure build-up in human tissue, we use the
insulin pen FlexTouch from Novo Nordisk A/S, which is an auto
injecting device, where the drug is injected by the force from a
torsion spring. The spring is twisted when the patient dials the dose
and as the spring is untwisted during the injection the device emits
a click for each 10 mL of drug which has been delivered. By
recording the click signal with a microphone we predict the flow
rate. One example of a click signal and the calculated flow rate is
shown in Figure 1 for an injection of 240 mL of insulin in air. It is
seen that the flow rate decreases throughout the injection as the
spring is untwisted and due to a special feature inside the pen the
spring force is reduced for the last part of the click signal, seen as a
drop in the flow rate after about 1.2 s. Therefore the last part of
the click signal has been omitted in our analysis.
In order to confirm that the flow rate calculated from the click
signal match the actual flow rate a series of injections were
performed in air where the click signal was recorded by a
microphone and the injected mass was measured on a scale,
simultaneously. Figure 2 shows an example of the flow rate as
calculated from the click signal (red curve) and from the injected
mass (blue curve). In total the flow rate was measured for 70
injections, using 10 different pens, and the injected dose was varied
from 150–800 mL. On average the deviation between the flow
calculated from the click signal and the injected mass was about
2%. This uncertainty is related to the flow rate prediction and not
to the total dose delivered, which has been shown to be very
accurate for this device [17,18].
Data collection
This study includes 11 men with type 2 diabetes. All the
injections were given subcutaneously in the abdomen using a
6 mm 31G needle and performed by the same nurse. The patients
were treated with NovoRapid U100 from Novo Nordisk A/S and
the dose injected was set by the treatment scheme of the
individual. Therefore the dose varies from 180 mL up to 480 mL.
Both before and after the subcutaneous injection given to the
patient, we record the click signal from a series of similar injections
in air. The difference in the flow rate between the injections in air
and in tissue relates to the counter pressure. After the injections the
radius of each of the needles was calculated from Eq. (4) (see the
Results section), by measuring the flow rate through the needle for
a known pressure.
Results
Insulin injected subcutaneously distributes between the fat
lobulus and forms a depot, as seen from the histological cross
section of a 100 mL insulin injection shown in Figure 3 (left). The
insulin has been dyed to appear red and it is seen how the needle
has penetrated dermis (blue skin layer). For the model of the tissue
mechanics we consider the tissue as a porous elastic medium.
Figure 3 (right) shows the 3 dimensional structure of a similar
injection depot visualized by X-ray computed tomography, where
the insulin drug has been diluted with an iodine based contrast
agent in order to distinguish the fluid from the tissue, as described
in a previous study [19]. The extension of the depot is about 1 cm
and we have observed that the shape of the depot vary from
injection to injection. For simplicity we assume, that the tissue is
homogeneous and that the drug is distributed spherical symmet-
rically around the injection site.
Figure 1. Click signal as emitted from the device and the flow
rate. The click signal (blue curve) is measured by a microphone and the
flow rate (red curve) is calculated from the time steps between the click
signal. This example is for an injection of 240 mL in air.
doi:10.1371/journal.pone.0104054.g001
Figure 2. Comparison of flow rate calculated from the click
signal and measured on a scale. The click signal and the injected
mass are measured simultaneously, to give the flow rate calculated
from the time steps between the click signals (red curve) and from the
injected mass between equal time steps (blue curve). The injected
volume was 400 mL.
doi:10.1371/journal.pone.0104054.g002
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In the description of the model we introduce a number of
variables and constants, which we for clarity have listed in
Table 1.
Mechanics of the injection device
The mechanical characteristics of the injection device is
analysed through a series of test experiments where the drug is
injected in air at atmospheric pressure. A simple schematic
illustration of the injection device is shown in Figure 4.
The pressure drop in the syringe due to viscous forces (DPsv) is
vanishingly small when compared with the pressure drop in the
needle (DPnv). The pressure drop in the needle consists of a
transient part, the entry length, over which the flow evolves to a
steady state parabolic Poiseuille flow and a final part where the
flow attains its parabolic shape (see Supporting Information S1). In
the syringe the flow does not reach the full parabolic form during
the short injections times considered here, however, an upper
estimate of the pressure drop is achieved by assuming that the flow
has reached a fully developed Poiseuille flow, which leads to
DPsv&10
{2Pa. The pressure drop in the needle is estimated from
the following expression derived in the Supporting Information
S1, Eq. (S30),
Ps{Po~
8g‘
pr4n
Q(t)z
1:01rf
p2r4n
Q2(t), ð1Þ
where g is the dynamic viscosity of the insulin drug, Q(t) is the
injection flow rate, rf is the mass density of the drug and ‘ and rn
denote the length and radius of the needle, respectively. We get for
typical injection flow rates Q(t)<100 mL/s a pressure drop in the
needle DPnv&10
5 Pa. The pressure drop in the needle is therefore
of the order 107 times larger than that in the syringe. Therefore,
we shall neglect the viscous forces inside the syringe in our
calculations below.
From the Bernoulli Equation we obtain that the pressure at the
inlet of the needle is approximately given by
Ps&
F (d)
pR2o
{
1
2
rf v
2
s , ð2Þ
where F (d) is the force delivered by the spring, R0 is the radius of
the syringe and vs denotes the average velocity over the cross
section at the needle inlet, which can be determined as
vs~
Q(t)
p r2n
, ð3Þ
Inserting Eq. (2) and (3) in Eq. (1), we obtain
F (d)
pR2o
{Po~
8g‘
p r4n
Q(t) 1z
Q(t)
5:29p n ‘
 
: ð4Þ
We now estimate the typical values of the second term inside the
parentheses in Eq. (4). In Figure 5, we observe that the largest flow
rates during the injection in air are approximately 150 mL/s.
Using the value of the kinematic viscosity of water
n~1:004:10{6
m2
s
and that the length of the needle is ‘~16:4
mm, we have that
Q(t)
5:29p n ‘
&0:55: ð5Þ
As for the case of the fluid injection in the tissue, we also observe in
Figure 5 that the largest flow rates are approximately 100 mL/s,
which leads to
Q(t)
5:29p n ‘
&0:37: ð6Þ
The second term in Eq. (4) therefore contributes significantly to
the the pressure drop between the syringe and the tissue/air and is
included in our model.
Pressure in the tissue
In the derivation of an equation for the pressure evolution in
tissue during injection we start from mass-conservation,
Lr
Lt
z+: rvð Þ~q(x,t), ð7Þ
where r is the mass of the injected drug per unit volume V , v is the
pore flow velocity in a unit volume and the local source term q(x,t)
is the mass of drug being injected per volume per time. A unit
volume in the tissue is assumed to comprises of the tissue (Vt) and
the injected drug (Vf ), i.e.
1~Vt=VzVf =V :
The drug density in a unit volume of tissue can be written in terms
of the mass density of the drug (rf ) as r~rf Vf =V , where Vf =V is
the local volume fraction of the drug. We introduce a field for the
local volume fraction of injected fluid w(x,t)~Vf =V in Eq. (7) and
end up with the equation:
Lw
Lt
z+: w~vð Þ~ q(x,t)
rf
, ð8Þ
Figure 3. Histological cross section (left) and X-ray computed
tomography scan (right) of similar subcutaneous injections.
The injections were performed in adipose pig tissue and the injected
volume was 100 mL. For histology the insulin has been dyed to appear
red in the light microscopy image. The segmented tomographic
reconstruction shows the 3 dimensional extension of the injection
depot together with the injection channel and the backflow at the skin
surface. The contrast between the tissue and the injected fluid is
obtained by mixing the insulin drug with an iodine based contrast
agent. The scale bar is 1 mm.
doi:10.1371/journal.pone.0104054.g003
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where ~v is the pore averaged flow velocity of the injected fluid in a
unit volume. Below we shall only consider the averaged velocity
and therefore for convenience omit the tilde over ~v.
The flow velocity is assumed to be given by the pressure
gradient through Darcy’s Law [12]
v~{
K
g
+p, ð9Þ
in which K is the permeability, g the dynamic viscosity of the fluid
and p is the pressure.
Moreover we assume that displacement of the tissue by the
injected fluid gives rise to a counter pressure, which will act to
restore the tissue structure. This pressure is in the most simple
approximation and for small deformations assumed to be linearly
proportional to the difference in local tissue porosity before (w0)
and after (w) displacement by the injected fluid
p(x,t){p0~b(w (x,t){w0), ð10Þ
where b is an effective bulk modulus describing the force needed to
locally displace the tissue. Note that this form of the pressure-
porosity relation is only valid for relatively small pressures, since
for a very large pressure this relation might even lead to a porosity
larger than unity, which would be highly non-physical. From Eq.
(8)–(10), we can now derive the following equation for the pressure
evolution in the tissue.
Lp
Lt
~
K
g
½(b w0zp{p0)+2pzD+pD2zb
q
rf
, ð11Þ
A similar equation is frequently encountered in studies on flows in
poro-elastic media [20,21] and in pattern formation studies of air
injection in granular media [22], where we here have assumed that
both the relative variation of volume and the advective contribu-
tion from the tissue motion are negligible.
We shall here take the tip of the needle as our center of
coordinates. For simplicity, the tissue surrounding the needle tip is
assumed to be homogeneous and isotropic and the injected fluid
will therefore be distributed in the tissue in a spherical symmetric
way. The equation for the pressure evolution is most conveniently
solved in spherical coordinates where the angular components by
symmetry can be disregarded. Since the source term is located at
the tip of the needle, we remove this term from the equation by
considering the pressure evolution outside a small sphere
surrounding the tip. The radius of this sphere is taken to be equal
to the radius of the needle rn and is therefore assumed to be
infinitesimal relative to the scales on which the fluid are
distributed. From Eq. (8) we then get from Gauss theorem, and
from the fact that mass cannot accumulate in an infinitesimal
volume, a boundary condition on the form,
Table 1. Table of constants and variables introduced in the text.
Ps(t) pressure at the inlet of the needle attached to the syringe [Pa]
P0 pressure at the outlet of the needle [Pa]
F (d) force delivered by the torsion spring [N]
d position of the piston head [m]
Ro inner radius of the syringe [m]
rn inner radius of the needle [m]
‘ length of the needle [m]
rf mass density of infused fluid in the tissue [kg/m
3]
vs average velocity over the cross section of the needle inlet [m/s]
Q(t) total injection rate in the tissue [m3/s]
n kinematic viscosity of the drug being infused [m2/s]
g dynamic viscosity of the drug being infused [Pa?s]
r(x,t) density of infused fluid in the tissue [kg/m3]
v average velocity of the injected fluid in a unit volume of pore space [m/s]
q(x,t) local injection rate of mass [kg/(m3?s)]
w(x,t) local volume fraction of infused fluid in the tissue [-]
w0 porosity of the tissue [-]
p(x,t) pressure in the tissue [Pa]
p0 tissue pressure without distortion [Pa]
b bulk modulus of the tissue [Pa]
K permeability of the tissue [m2]
doi:10.1371/journal.pone.0104054.t001
Figure 4. Schematic illustration of the insulin injection device.
The force, F, acting on the piston from the torsion spring is a function of
position, d, of the piston.
doi:10.1371/journal.pone.0104054.g004
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4pr2n(wvr)Dr~rn~Q(t) ð12Þ
where vr is the radial component of the fluid velocity and the flow
rate Q(t)~(4=3)p r3n
Ð
q=rf dV : If we now make use of Darcy’s
law, we end with the following boundary condition for the pressure
Lp
LrDr~rn~{
gQ(t)
4pr2nwK
, ð13Þ
where the porosity w is calculated from the pressure through Eq.
(10).
Experimental data on subcutaneous injection
As examples of the flow data, Figure 5 shows the measurements
from 3 of the 11 patients. From Eq. (4), we can directly estimate
the function F (d) from the injections in air, since the atmospheric
pressure, P0, is known (note that variations in the atmospheric
pressure have a negligible impact on our calculations and it is
assumed that the friction force between the rubber piston and the
syringe is independent on the flow rate). From our estimate of
F (d), the drug injection rate and from Eq. (11) and (12), we can
calculate the pressure evolution in the tissue once we know the
model parameters K , b and w0. The other parameters like the
viscosity of water (g) and atmospheric pressure (p0) are known. The
far field pressure in the tissue (away from the needle) is assumed to
be equal to atmospheric pressure. In general, however, the
pressure in subcutaneous tissue might be slightly below atmo-
spheric pressure [13]. The pressure at the outlet of the needle tip is
calculated from the function F (d) and the injection rate by using
Eq. 4, where P0 now is the pressure in the tissue and is a function
of time. The average tissue counter pressure is shown in a box plot
in Figure 6. Three patients has been omitted, as no change in the
flow rate was observed indicating a low tissue resistance. We then
compare the pressure P0(t) in the tissue with that predicted by the
model at the needle tip, p(rn,t), in order to find the free model
parameters through a best fit (least squares). Note that in our
calculation of p(rn,t), we use the flow rate as a boundary condition,
given by Eq. (12). In Figure 7 we show P0(t) together with the
model estimate p(rn,t) achieved by a best fit. The pressure
evolution in radial distance from the needle tip and over time is
presented in Figure 8. We see that the over-pressure is more or less
localized in a sphere with a radius less than 5 mm, which is
consistent with the distribution shown in Figure 3 (right).
In Figure 9A we show a box plot of the permeability computed
from a best fit with the model to the patient data, again where
three patients have been omitted. The typical permeability is from
Figure 5. Flow rate during injection in air and in subcutis on
three different patients. A significant drop in the flow rate is seen
when the drug is injected in the tissue. The final and sudden jump in
the flow rate in the panels (B) and (C) is due to an intended change in
the mechanics of the syringe at end of the injection.
doi:10.1371/journal.pone.0104054.g005
Figure 6. Average tissue counter pressure for eight patients.
The boarder of the box is from the first to the third quartiles, with the
median value marked as a black line. The whisker extend to the extreme
values. The pressure is estimated from Eq. (4) using F (d) estimated from
the reference measurements in air and the flow rate Q(t) in tissue.
doi:10.1371/journal.pone.0104054.g006
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the model estimated to be of the order 10{11{10{10 m2. From
the interquartile range, we estimate the 95% confidence interval
(the notch [23]) to be between K~ 8:9+4:7ð Þ:10{11 m2.
Measurements of the permeability in porcine adipose tissue [24]
gave values of the same order of magnitudes as reported in this
article. The estimated values of the bulk modulus are shown in
Figure 9B with a 95% confidence interval between the values
b~ 0:89+0:13ð Þ:105 Pa. Note that at the outlet of the needle, the
Figure 7. Pressure in the tissue during drug injection for three
different patients. The pressure at the outlet of the needle (full line)
is estimated from the spring force on the piston using the data on
injection in air in Figure 5. The model prediction (dashed line) of the
same pressure is computed from Eq. (11) and (12) by using the
measured flow rate Q(t) as a boundary condition. The pressure curves
(A–C) corresponds to the flow rates shown in Figure 5 (A–C).
doi:10.1371/journal.pone.0104054.g007
Figure 8. Pressure evolution in the tissue. The pressure in the
tissue as function of the radial distance from the needle tip at different
times (in seconds). Initially the over-pressure is localized around the tip
of the needle and then quickly becomes distributed in the surrounding
tissue.
doi:10.1371/journal.pone.0104054.g008
Figure 9. Box plots of the tissue permeability and bulk
modulus. The values are estimated from best fits to the patient data.
The permeability estimates are presented in panel (A) and the bulk
modulus in panel (B). The middle line of the plot represents the value of
the median and the outer edges of the box represent lower and upper
quartiles, respectively. The whiskers extend to the extreme values.
doi:10.1371/journal.pone.0104054.g009
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pressure in the tissue does for a few patients reach levels which are
not fully consistent with a constitutive equation on the form of Eq.
(10), i.e. the tissue porosity reaches values close to unity or might
slightly exceed it. One way to remedy this is to change the
constitutive equation and include higher order elastic or plastic
effects. That being said, the pressure in the tissue does immediately
drop slightly away from the needle tip (see Figure 8) and Eq. (10)
becomes a valid description. Finally the background porosity w0 is
in general very small and of the order *0:01.
Discussion
Using a simple experimental setup we have been able to
estimate the average tissue counter pressure during a subcutaneous
injection with an insulin pen. The major advantages of this setup it
that we do not modify the injection device and therefore are able
to evaluate the pressure built up under normal injection
conditions. We observe large variations in the counter pressure
from a very low pressure, not detectable with this method, and up
to pressures of about 800 mbar. All injections where performed
with out complications, meaning that no skin reactions or pain
during or after the injections were observed.
We have derived a model for the pressure evolution during
injection in subcutaneous tissue, based on mass continuity as well
as the basic laws of viscous flow in a poro-elastic medium. From
application of the model to data on the insulin injections in
diabetic patients, we have been able to determine flow perme-
ability and bulk modulus of the tissue. Our model makes it possible
to estimate how changes in the flow permeability and bulk
modulus effect the pressure build-up in subcutaneous tissue during
drug infusion, which is an important part of designing injection
devices for insulin treatment. Control ensures that the device can
deliver the full dose, that the back-flow through the injection
channel is minimized and that injection pain or even tissue
damage is reduced. Furthermore, our model, using the fitted
parameters, is useful in general predictions of tissue pressure
changes when mechanics of the injection device or the size of the
needle is changed. Using the non-invasive method presented here
the changes in counter pressure can easily be evaluated during
clinical trails.
Supporting Information
Supporting Information S1 Total pressure drop along the
needle.
(PDF)
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